Corneal Sensitivity in Patients With Sleep Apnea Syndrome
NCT ID: NCT02265133
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2015-07-17
2024-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patient recruitment will be complete at the one-year time point. At the 14 month time point, all data points will have been collected and assessment of the outcome measure (corneal sensitivity in sleep apnea patients versus control patients) will be complete.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
NCT06023927
Regulation of Vascular Thrombosis in Sleep Apnea
NCT00859690
Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
NCT02034175
Obstructive Sleep Apnoea in Patients With Type 1 Diabetes
NCT03481361
SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study
NCT06711159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Testing procedures: The visit will include:
Slit Lamp Microscopy:
An ocular examination of the external (lids, lashes) along with internal (cornea, lens, retina) structures of the eye can be performed with the aid of a slit lamp. This instruments uses lenses and an external light source that can be refracted at different angles and intensities to assess ocular structures for diagnostic purposes.
Corneal sensitivity measurement:
1. Corneal touch sensitivity will be determined using a Cochet-Bonnet aesthesiometer mounted on a standard slit lamp biomicroscope. The Cochet-Bonnet aesthesiometer is routinely used for clinical research purposes to investigate corneal touch thresholds.
2. For sensitivity measurements, a 0.12 mm diameter nylon thread will be slowly brought forward to briefly touch the cornea perpendicularly and then quickly withdrawn.
3. On each occasion, the patient will be asked to respond whenever a stimulus is felt.
4. Thread length is used to quantitatively assess sensitivity. The longest thread length is used first (6 cm), as this provides the lowest stimulus intensity.
5. If the subject is unable to detect the touch stimulus, the thread will be systematically shortened in length by 0.5 cm steps until the stimulus is felt.
6. The criterion for the sensitivity threshold will be the filament length which gives a 50% positive response from four stimulus applications.
In Vivo Confocal Microscope
1. Corneal nerves will be imaged using a modified in vivo confocal microscope which is routinely used in our clinics (HRT Rostock corneal module, Heidelberg Engineering).
2. The HRT In Vivo Confocal microscope was modified by adding a motor to automate the focus. This does not alter the integrity, the application, the intent or the light source of the instrument.
3. Corneas will be anesthetized with a topical anesthetic, proparacaine, prior to scanning.
4. The confocal microscope will briefly touch the patient's eye and the images saved for further analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with a diagnosis of sleep apnea.
3. Non-contact lens wearers of any gender and race, ages 18 and up.
4. Minority representation will be proactively encouraged.
5. Patients that are willing to review, understand, and sign the written Informed Consent.
6. Written authorization for use or release of health and research study information.
7. Patients that are willing and able to cooperate with the Investigator and follow all instructions.
Exclusion Criteria
2. Previous history of corneal surgery.
3. Previous history of ocular trauma.
4. History of Diabetes Mellitus.
5. Current active or previous history of Herpes virus keratitis.
6. Current or former Contact lens wear.
7. Chronic history of dry eye disease.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danielle Robertson
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Robertson, O.D, PhD
Role: PRINCIPAL_INVESTIGATOR
UTSW Medical Center at Dallas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkland Hospital
Dallas, Texas, United States
Aston Ambulatory Care Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU 102011-033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.